Kendall Hunter
Concepts (296)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Artery | 34 | 2025 | 1116 | 3.750 |
Why?
| | Ventricular Function, Right | 23 | 2026 | 300 | 3.240 |
Why?
| | Ventricular Dysfunction, Right | 15 | 2026 | 248 | 3.110 |
Why?
| | Hypertension, Pulmonary | 38 | 2026 | 1957 | 3.040 |
Why?
| | Heart Ventricles | 25 | 2026 | 762 | 2.990 |
Why?
| | Vascular Stiffness | 25 | 2023 | 488 | 2.220 |
Why?
| | Models, Cardiovascular | 13 | 2020 | 194 | 1.610 |
Why?
| | Pulmonary Circulation | 13 | 2022 | 431 | 1.330 |
Why?
| | Magnetic Resonance Imaging, Cine | 13 | 2025 | 214 | 1.320 |
Why?
| | Stroke Volume | 15 | 2023 | 652 | 1.180 |
Why?
| | Echocardiography, Three-Dimensional | 4 | 2026 | 71 | 1.130 |
Why?
| | Hemodynamics | 17 | 2025 | 1114 | 1.040 |
Why?
| | Blood Pressure | 12 | 2021 | 1765 | 1.000 |
Why?
| | Arterial Pressure | 5 | 2019 | 130 | 0.900 |
Why?
| | Vascular Resistance | 11 | 2022 | 365 | 0.890 |
Why?
| | Cardiac Catheterization | 14 | 2026 | 571 | 0.880 |
Why?
| | Echocardiography | 10 | 2024 | 645 | 0.830 |
Why?
| | Fontan Procedure | 6 | 2023 | 200 | 0.820 |
Why?
| | Imaging, Three-Dimensional | 4 | 2013 | 582 | 0.760 |
Why?
| | Phantoms, Imaging | 2 | 2014 | 160 | 0.730 |
Why?
| | Magnetic Resonance Angiography | 4 | 2019 | 249 | 0.710 |
Why?
| | Blood Flow Velocity | 8 | 2019 | 419 | 0.690 |
Why?
| | Magnetic Resonance Imaging | 14 | 2025 | 3926 | 0.690 |
Why?
| | Forecasting | 1 | 2021 | 388 | 0.600 |
Why?
| | Carotid Arteries | 3 | 2018 | 206 | 0.550 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2017 | 66 | 0.520 |
Why?
| | Heart-Assist Devices | 5 | 2025 | 572 | 0.520 |
Why?
| | Heart Defects, Congenital | 5 | 2024 | 923 | 0.500 |
Why?
| | Computer Simulation | 9 | 2019 | 1014 | 0.500 |
Why?
| | Ventricular Function, Left | 6 | 2025 | 541 | 0.480 |
Why?
| | Heart Failure | 7 | 2026 | 2329 | 0.470 |
Why?
| | Aorta, Thoracic | 6 | 2023 | 284 | 0.460 |
Why?
| | Echinococcosis, Pulmonary | 1 | 2015 | 7 | 0.460 |
Why?
| | Collagen | 6 | 2014 | 460 | 0.440 |
Why?
| | Elastic Modulus | 4 | 2013 | 121 | 0.430 |
Why?
| | Ventricular Dysfunction, Left | 4 | 2025 | 391 | 0.420 |
Why?
| | Aorta | 6 | 2020 | 440 | 0.410 |
Why?
| | Child | 33 | 2023 | 22693 | 0.400 |
Why?
| | Male | 55 | 2026 | 73396 | 0.390 |
Why?
| | Industry | 1 | 2013 | 43 | 0.380 |
Why?
| | Cattle | 10 | 2023 | 940 | 0.380 |
Why?
| | Fetal Growth Retardation | 3 | 2013 | 592 | 0.370 |
Why?
| | Predictive Value of Tests | 11 | 2026 | 2113 | 0.370 |
Why?
| | Hypoxia | 5 | 2024 | 1211 | 0.370 |
Why?
| | Portal Vein | 1 | 2014 | 123 | 0.370 |
Why?
| | Pulmonary Valve Insufficiency | 1 | 2012 | 49 | 0.350 |
Why?
| | Tetralogy of Fallot | 1 | 2012 | 76 | 0.350 |
Why?
| | Humans | 70 | 2026 | 146342 | 0.340 |
Why?
| | Placental Insufficiency | 1 | 2013 | 126 | 0.340 |
Why?
| | Ultrasonography | 2 | 2026 | 788 | 0.330 |
Why?
| | Female | 50 | 2026 | 79499 | 0.330 |
Why?
| | Diagnostic Imaging | 1 | 2014 | 340 | 0.330 |
Why?
| | Adolescent | 26 | 2025 | 22557 | 0.320 |
Why?
| | Myocardial Contraction | 4 | 2020 | 292 | 0.310 |
Why?
| | Case-Control Studies | 15 | 2026 | 3647 | 0.310 |
Why?
| | Blood Pressure Determination | 2 | 2008 | 143 | 0.310 |
Why?
| | Elasticity | 6 | 2015 | 187 | 0.310 |
Why?
| | Pulse Wave Analysis | 6 | 2023 | 268 | 0.310 |
Why?
| | Extracellular Matrix | 5 | 2021 | 565 | 0.300 |
Why?
| | Stress, Physiological | 1 | 2012 | 450 | 0.280 |
Why?
| | Hypoplastic Left Heart Syndrome | 2 | 2020 | 119 | 0.270 |
Why?
| | Aortic Diseases | 2 | 2021 | 125 | 0.270 |
Why?
| | Fetus | 1 | 2013 | 800 | 0.270 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2021 | 778 | 0.270 |
Why?
| | Stress, Mechanical | 9 | 2019 | 497 | 0.260 |
Why?
| | Image Interpretation, Computer-Assisted | 4 | 2018 | 295 | 0.260 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2021 | 928 | 0.250 |
Why?
| | Algorithms | 5 | 2026 | 1849 | 0.250 |
Why?
| | Elastin | 6 | 2015 | 78 | 0.250 |
Why?
| | Retrospective Studies | 18 | 2023 | 17438 | 0.250 |
Why?
| | Infant | 12 | 2021 | 10114 | 0.240 |
Why?
| | Cardiac Output | 4 | 2020 | 176 | 0.240 |
Why?
| | Heart Septal Defects | 1 | 2006 | 12 | 0.240 |
Why?
| | Follow-Up Studies | 6 | 2025 | 5439 | 0.240 |
Why?
| | Vasomotor System | 1 | 2006 | 47 | 0.240 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2025 | 2623 | 0.230 |
Why?
| | Pneumothorax | 1 | 2026 | 54 | 0.230 |
Why?
| | Myocardial Perfusion Imaging | 1 | 2025 | 50 | 0.230 |
Why?
| | Abdominal Fat | 1 | 2025 | 51 | 0.220 |
Why?
| | Prospective Studies | 11 | 2026 | 8123 | 0.220 |
Why?
| | Regional Blood Flow | 4 | 2021 | 507 | 0.220 |
Why?
| | Child, Preschool | 14 | 2023 | 11913 | 0.210 |
Why?
| | Animals | 23 | 2026 | 38107 | 0.210 |
Why?
| | Reproducibility of Results | 7 | 2018 | 3416 | 0.210 |
Why?
| | Arteries | 2 | 2018 | 261 | 0.210 |
Why?
| | Heart | 2 | 2025 | 626 | 0.200 |
Why?
| | Heart Transplantation | 2 | 2023 | 682 | 0.200 |
Why?
| | Models, Biological | 1 | 2011 | 1761 | 0.200 |
Why?
| | Gastrectomy | 1 | 2025 | 164 | 0.200 |
Why?
| | Tomography, X-Ray Computed | 2 | 2018 | 2786 | 0.200 |
Why?
| | Overweight | 2 | 2025 | 614 | 0.190 |
Why?
| | Myocardium | 3 | 2023 | 948 | 0.190 |
Why?
| | Patient-Specific Modeling | 3 | 2020 | 46 | 0.190 |
Why?
| | Materials Testing | 2 | 2017 | 345 | 0.190 |
Why?
| | Cardiorespiratory Fitness | 2 | 2025 | 73 | 0.190 |
Why?
| | Electrocardiography | 2 | 2023 | 667 | 0.180 |
Why?
| | Umbilical Arteries | 2 | 2013 | 51 | 0.180 |
Why?
| | Severity of Illness Index | 6 | 2019 | 2921 | 0.180 |
Why?
| | Perfusion Imaging | 2 | 2019 | 66 | 0.170 |
Why?
| | Endothelial Cells | 3 | 2023 | 876 | 0.170 |
Why?
| | Assisted Circulation | 1 | 2021 | 26 | 0.170 |
Why?
| | Disease Models, Animal | 8 | 2026 | 4580 | 0.170 |
Why?
| | Sensitivity and Specificity | 4 | 2018 | 1998 | 0.170 |
Why?
| | Glycopeptides | 1 | 2021 | 48 | 0.160 |
Why?
| | Arrhythmias, Cardiac | 1 | 2023 | 358 | 0.160 |
Why?
| | Adipose Tissue | 1 | 2025 | 642 | 0.160 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2021 | 110 | 0.160 |
Why?
| | Exercise | 2 | 2024 | 2213 | 0.150 |
Why?
| | Ventricular Pressure | 1 | 2019 | 52 | 0.150 |
Why?
| | Cardiovascular Diseases | 2 | 2023 | 2219 | 0.150 |
Why?
| | Peptide Fragments | 2 | 2021 | 693 | 0.150 |
Why?
| | Oxygen Consumption | 2 | 2024 | 721 | 0.140 |
Why?
| | Age Factors | 5 | 2019 | 3347 | 0.140 |
Why?
| | Marfan Syndrome | 1 | 2018 | 44 | 0.140 |
Why?
| | Sheep | 4 | 2014 | 870 | 0.140 |
Why?
| | Models, Theoretical | 2 | 2013 | 561 | 0.140 |
Why?
| | Neuroendocrine Cells | 1 | 2018 | 34 | 0.140 |
Why?
| | Lung | 5 | 2015 | 4122 | 0.130 |
Why?
| | Pediatric Obesity | 1 | 2025 | 635 | 0.130 |
Why?
| | Microcirculation | 2 | 2016 | 142 | 0.130 |
Why?
| | Thermodilution | 1 | 2017 | 16 | 0.130 |
Why?
| | Turner Syndrome | 1 | 2018 | 61 | 0.130 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2018 | 88 | 0.130 |
Why?
| | Cardiac Surgical Procedures | 1 | 2024 | 611 | 0.130 |
Why?
| | Pilot Projects | 4 | 2026 | 1888 | 0.130 |
Why?
| | Prognosis | 5 | 2019 | 4351 | 0.130 |
Why?
| | Echocardiography, Doppler | 1 | 2018 | 117 | 0.130 |
Why?
| | Aortic Coarctation | 1 | 2018 | 76 | 0.130 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2018 | 96 | 0.130 |
Why?
| | Shear Strength | 3 | 2018 | 73 | 0.120 |
Why?
| | ROC Curve | 2 | 2015 | 617 | 0.120 |
Why?
| | Middle Aged | 12 | 2026 | 36619 | 0.120 |
Why?
| | Pressure | 2 | 2019 | 221 | 0.120 |
Why?
| | Hemorheology | 1 | 2016 | 24 | 0.120 |
Why?
| | Nitric Oxide | 1 | 2021 | 883 | 0.120 |
Why?
| | Glycocalyx | 1 | 2016 | 30 | 0.120 |
Why?
| | Arterioles | 1 | 2016 | 52 | 0.120 |
Why?
| | Physical Conditioning, Animal | 1 | 2018 | 243 | 0.120 |
Why?
| | Biomimetic Materials | 1 | 2017 | 78 | 0.120 |
Why?
| | Adaptation, Physiological | 2 | 2018 | 568 | 0.110 |
Why?
| | Principal Component Analysis | 3 | 2023 | 192 | 0.110 |
Why?
| | Capillaries | 1 | 2016 | 123 | 0.110 |
Why?
| | Compliance | 2 | 2012 | 50 | 0.110 |
Why?
| | Familial Primary Pulmonary Hypertension | 4 | 2021 | 194 | 0.110 |
Why?
| | Area Under Curve | 1 | 2015 | 335 | 0.110 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2017 | 271 | 0.110 |
Why?
| | Signal Processing, Computer-Assisted | 2 | 2023 | 152 | 0.110 |
Why?
| | Endotoxins | 1 | 2015 | 215 | 0.110 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2022 | 3930 | 0.110 |
Why?
| | Tissue Scaffolds | 1 | 2017 | 223 | 0.100 |
Why?
| | Pulsatile Flow | 1 | 2014 | 62 | 0.100 |
Why?
| | Adventitia | 1 | 2014 | 42 | 0.100 |
Why?
| | Animals, Newborn | 3 | 2015 | 888 | 0.100 |
Why?
| | Image Enhancement | 1 | 2015 | 198 | 0.100 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2017 | 449 | 0.100 |
Why?
| | Bronchi | 1 | 2015 | 263 | 0.100 |
Why?
| | Cardiography, Impedance | 1 | 2013 | 9 | 0.100 |
Why?
| | Software | 2 | 2023 | 676 | 0.100 |
Why?
| | Young Adult | 8 | 2021 | 14330 | 0.100 |
Why?
| | Contrast Media | 1 | 2017 | 493 | 0.100 |
Why?
| | Aorta, Abdominal | 1 | 2013 | 51 | 0.100 |
Why?
| | Oscillometry | 1 | 2013 | 35 | 0.100 |
Why?
| | Toll-Like Receptor 2 | 1 | 2014 | 125 | 0.100 |
Why?
| | Time Factors | 4 | 2021 | 7109 | 0.100 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 2014 | 132 | 0.100 |
Why?
| | Precision Medicine | 1 | 2017 | 462 | 0.090 |
Why?
| | Polymers | 1 | 2017 | 488 | 0.090 |
Why?
| | Ultrasonography, Doppler, Color | 2 | 2010 | 37 | 0.090 |
Why?
| | Vasodilation | 3 | 2025 | 519 | 0.090 |
Why?
| | Equipment Design | 1 | 2014 | 520 | 0.090 |
Why?
| | Vitamin D | 1 | 2015 | 402 | 0.090 |
Why?
| | Reference Values | 2 | 2017 | 796 | 0.090 |
Why?
| | Lung Diseases, Interstitial | 1 | 2018 | 677 | 0.090 |
Why?
| | Models, Statistical | 1 | 2015 | 669 | 0.080 |
Why?
| | Elastic Tissue | 1 | 2011 | 10 | 0.080 |
Why?
| | Fibrillar Collagens | 1 | 2011 | 15 | 0.080 |
Why?
| | Linear Models | 2 | 2018 | 857 | 0.080 |
Why?
| | MicroRNAs | 1 | 2017 | 699 | 0.080 |
Why?
| | Feasibility Studies | 1 | 2015 | 1135 | 0.080 |
Why?
| | Rats, Wistar | 2 | 2025 | 451 | 0.080 |
Why?
| | Pre-Eclampsia | 1 | 2013 | 206 | 0.080 |
Why?
| | Ultrasonography, Doppler, Pulsed | 1 | 2010 | 7 | 0.080 |
Why?
| | NF-kappa B | 1 | 2014 | 674 | 0.080 |
Why?
| | Pregnancy | 5 | 2015 | 7230 | 0.080 |
Why?
| | Biomarkers | 2 | 2021 | 4340 | 0.080 |
Why?
| | Rats | 4 | 2025 | 5586 | 0.070 |
Why?
| | Vasodilator Agents | 1 | 2011 | 326 | 0.070 |
Why?
| | Biomechanical Phenomena | 4 | 2017 | 874 | 0.070 |
Why?
| | Ultrasonics | 1 | 2009 | 50 | 0.070 |
Why?
| | Uncertainty | 1 | 2010 | 145 | 0.070 |
Why?
| | Microbubbles | 1 | 2009 | 51 | 0.070 |
Why?
| | Exercise Test | 2 | 2024 | 637 | 0.070 |
Why?
| | Ventricular Remodeling | 2 | 2023 | 283 | 0.070 |
Why?
| | Hypertrophy, Right Ventricular | 2 | 2023 | 151 | 0.070 |
Why?
| | Cross-Sectional Studies | 4 | 2025 | 5899 | 0.070 |
Why?
| | Fibrosis | 2 | 2021 | 568 | 0.070 |
Why?
| | Mechanotransduction, Cellular | 2 | 2023 | 121 | 0.070 |
Why?
| | Reference Standards | 1 | 2008 | 176 | 0.060 |
Why?
| | Logistic Models | 2 | 2015 | 2126 | 0.060 |
Why?
| | Ultrasonography, Doppler | 1 | 2008 | 122 | 0.060 |
Why?
| | Electric Impedance | 1 | 2007 | 108 | 0.060 |
Why?
| | Postoperative Complications | 1 | 2020 | 3034 | 0.060 |
Why?
| | Risk Factors | 3 | 2017 | 10921 | 0.060 |
Why?
| | Probability | 1 | 2007 | 309 | 0.060 |
Why?
| | Adult | 6 | 2026 | 41087 | 0.050 |
Why?
| | Adipose Tissue, Brown | 1 | 2025 | 60 | 0.050 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2025 | 199 | 0.050 |
Why?
| | Hypertension | 2 | 2012 | 1272 | 0.050 |
Why?
| | Protein-Losing Enteropathies | 1 | 2023 | 10 | 0.050 |
Why?
| | Chronic Disease | 1 | 2010 | 1827 | 0.050 |
Why?
| | Swine | 1 | 2026 | 821 | 0.050 |
Why?
| | Disease Progression | 3 | 2018 | 2867 | 0.050 |
Why?
| | Bromocriptine | 1 | 2022 | 31 | 0.050 |
Why?
| | Glycosaminoglycans | 2 | 2013 | 79 | 0.050 |
Why?
| | Treatment Outcome | 2 | 2018 | 11821 | 0.050 |
Why?
| | Matrix Metalloproteinases, Secreted | 1 | 2021 | 12 | 0.040 |
Why?
| | ADAMTS4 Protein | 1 | 2021 | 16 | 0.040 |
Why?
| | Long Term Adverse Effects | 1 | 2021 | 13 | 0.040 |
Why?
| | Temperature | 1 | 2025 | 635 | 0.040 |
Why?
| | Heart Murmurs | 1 | 2021 | 13 | 0.040 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2021 | 17 | 0.040 |
Why?
| | Adiposity | 1 | 2025 | 533 | 0.040 |
Why?
| | Cross-Over Studies | 1 | 2022 | 615 | 0.040 |
Why?
| | Aged | 4 | 2025 | 26432 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2021 | 567 | 0.040 |
Why?
| | Coronary Circulation | 1 | 2020 | 134 | 0.040 |
Why?
| | Vascular Remodeling | 1 | 2021 | 208 | 0.040 |
Why?
| | Dimensional Measurement Accuracy | 1 | 2019 | 11 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 441 | 0.040 |
Why?
| | Rabbits | 1 | 2019 | 651 | 0.030 |
Why?
| | Diastole | 1 | 2018 | 147 | 0.030 |
Why?
| | Heart Failure, Diastolic | 1 | 2018 | 23 | 0.030 |
Why?
| | Mitochondria | 1 | 2025 | 997 | 0.030 |
Why?
| | Comparative Effectiveness Research | 1 | 2019 | 171 | 0.030 |
Why?
| | Pediatrics | 1 | 2006 | 1124 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 2 | 2015 | 2537 | 0.030 |
Why?
| | Hyperplasia | 1 | 2018 | 164 | 0.030 |
Why?
| | Electrophysiologic Techniques, Cardiac | 1 | 2018 | 82 | 0.030 |
Why?
| | Postoperative Period | 1 | 2018 | 355 | 0.030 |
Why?
| | Rare Diseases | 1 | 2018 | 117 | 0.030 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 121 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2021 | 1712 | 0.030 |
Why?
| | Mitochondria, Heart | 1 | 2018 | 107 | 0.030 |
Why?
| | Aftercare | 1 | 2019 | 225 | 0.030 |
Why?
| | Heart Valve Diseases | 1 | 2018 | 151 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2018 | 426 | 0.030 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 103 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2017 | 60 | 0.030 |
Why?
| | Vasoconstriction | 1 | 2018 | 216 | 0.030 |
Why?
| | Education | 1 | 2017 | 103 | 0.030 |
Why?
| | Activities of Daily Living | 1 | 2020 | 442 | 0.030 |
Why?
| | Blood Viscosity | 1 | 2016 | 19 | 0.030 |
Why?
| | Exercise Tolerance | 1 | 2018 | 289 | 0.030 |
Why?
| | Proteomics | 1 | 2023 | 1203 | 0.030 |
Why?
| | Respiratory Physiological Phenomena | 1 | 2015 | 34 | 0.030 |
Why?
| | Capillary Permeability | 1 | 2016 | 133 | 0.030 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2016 | 80 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 365 | 0.030 |
Why?
| | Risk | 1 | 2018 | 920 | 0.030 |
Why?
| | Aortic Valve | 1 | 2018 | 360 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1298 | 0.030 |
Why?
| | Myocardial Ischemia | 1 | 2017 | 286 | 0.030 |
Why?
| | Demography | 1 | 2015 | 274 | 0.030 |
Why?
| | Postoperative Care | 1 | 2017 | 301 | 0.030 |
Why?
| | Hematocrit | 1 | 2014 | 108 | 0.030 |
Why?
| | Tricuspid Valve | 1 | 2014 | 42 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2014 | 230 | 0.020 |
Why?
| | Phosphatidylcholines | 1 | 2014 | 131 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2014 | 335 | 0.020 |
Why?
| | Cardiomyopathies | 1 | 2017 | 340 | 0.020 |
Why?
| | Altitude Sickness | 1 | 2014 | 141 | 0.020 |
Why?
| | Toll-Like Receptor 4 | 1 | 2014 | 277 | 0.020 |
Why?
| | Survival Rate | 1 | 2017 | 2092 | 0.020 |
Why?
| | Infant, Newborn | 2 | 2014 | 6460 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 633 | 0.020 |
Why?
| | Up-Regulation | 1 | 2014 | 841 | 0.020 |
Why?
| | Mice | 2 | 2021 | 18297 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 2014 | 561 | 0.020 |
Why?
| | Species Specificity | 1 | 2011 | 543 | 0.020 |
Why?
| | Erythrocytes | 1 | 2016 | 750 | 0.020 |
Why?
| | Obesity | 1 | 2023 | 3131 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4118 | 0.020 |
Why?
| | Gestational Age | 1 | 2012 | 990 | 0.020 |
Why?
| | Hyperbaric Oxygenation | 1 | 2008 | 39 | 0.020 |
Why?
| | Tunica Media | 1 | 2007 | 39 | 0.020 |
Why?
| | Finite Element Analysis | 1 | 2007 | 67 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2008 | 563 | 0.020 |
Why?
| | Tunica Intima | 1 | 2007 | 80 | 0.020 |
Why?
| | Protein Conformation | 1 | 2008 | 916 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2012 | 2502 | 0.010 |
Why?
| | Radiography | 1 | 2007 | 861 | 0.010 |
Why?
| | Colorado | 1 | 2014 | 4595 | 0.010 |
Why?
| | Research Design | 1 | 2010 | 1143 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2014 | 6034 | 0.010 |
Why?
| | Inflammation | 1 | 2014 | 2919 | 0.010 |
Why?
| | United States | 1 | 2017 | 16136 | 0.010 |
Why?
|
|
Hunter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|